Important effects of cyproterone acetate on endometriosis? 2002

Carlos Moran

UI MeSH Term Description Entries
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D004715 Endometriosis A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum. Endometrioma,Endometriomas,Endometrioses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017373 Cyproterone Acetate An agent with anti-androgen and progestational properties. It shows competitive binding with dihydrotestosterone at androgen receptor sites. Androcur,Cyproterone Acetate, (1 alpha,2 alpha)-Isomer,Cyproterone Acetate, (1 alpha,2 alpha,9 beta,10 alpha)-Isomer,Cyproterone Acetate, (17 alpha)-Isomer

Related Publications

Carlos Moran
January 1996, Archives of medical research,
Carlos Moran
November 1977, Experientia,
Carlos Moran
January 1989, Meikai Daigaku shigaku zasshi = The Journal of Meikai University School of Dentistry,
Carlos Moran
October 1977, Deutsche medizinische Wochenschrift (1946),
Carlos Moran
March 1975, Journal of pharmaceutical sciences,
Carlos Moran
May 1982, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
Carlos Moran
November 1976, Lancet (London, England),
Copied contents to your clipboard!